Max International Assigned Patent to Ribose-Cysteine (RiboCeine®), a Groundbreaking Health-Enhancing Compound

Max International, a global supplier and wholesale distributor of energy- and health-enhancing products, has been assigned the U.S. patent for RiboCeine by its creator, Dr. Herbert Nagasawa.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Max International Headquarters

Co-CEO, Dave Bagley, comments, “I have never seen a company more focused on scientific development than Max International.”

Salt Lake City, UT (PRWEB) August 05, 2014

Max International, a global supplier and wholesale distributor of energy- and health-enhancing products, has been assigned the U.S. patent for RiboCeine by its creator, Dr. Herbert Nagasawa. RiboCeine is a revolutionary compound shown to enhance the delivery of Glutathione and ATP levels in the cells. As a component in several of the company’s formulated supplements, RiboCeine has been shown to help cells regain and maintain ATP and GSH levels, both to improve tissue survival and to hasten recovery.

Max International has been assigned the U.S. Patent 8,501,700 by renowned medicinal chemist and chief product scientist Dr. Herbert Nagasawa for the breakthrough compound, RiboCeine. Developed by Dr. Nagasawa and his team of scientific researchers, RiboCeine technology is used to give Max International’s products their health maintenance and energy recovery qualities. RiboCeine is a proprietary combination of D-ribose and L-cysteine that enhances the delivery of glutathione (GSH) and the production of adenosine triphosphate (ATP) levels in cells. With the assignment of this patent, Max International now fully owns the revolutionary compound used in several of its health-enhancing supplements.

Inspired to help his brother battle the health-deteriorating effects of alcoholism after returning from the Vietnam War (a widespread issue among veterans returning from the war), Dr. Nagasawa was determined to find a solution to this pervasive health problem. He worked for years to develop a drug that could protect the liver from the ravages of alcohol and eventually found that stimulating cells to produce more glutathione was shown to protect the liver from the oxidative stress of substances that are toxic to the liver, such as alcohol. Ribose-cysteine (i.e. RiboCeine) has been shown to effectively deliver L-cysteine to cells, which stimulates glutathione biosynthesis and protects cells from toxins. Furthermore, since RiboCeine is made from endogenous substances (D-ribose) alreheadsady present in the human body, it represents an ideal dietary supplement for increasing overall glutathione and ATP levels.

RiboCeine assists in the stimulation of glutathione and ATP production. Since glutathione (which is produced naturally in the body) is the primary protector and detoxifier of cells and ATP is the chemical energy source for metabolism, RiboCeine helps to support the immune system, the normal detoxification of environmental toxins, as well as the neutralization of numerous types of free radicals. Max International uses the revolutionary RiboCeine technology in many of its health-enhancing supplements, including Cellgevity, MaxOne, and MaxATP.

The acquisition of the patent demonstrates Max Intl.’s commitment to developing real health breakthroughs backed by scientific research, leading the wellness and nutritional industry by delivering the highest-quality proprietary products. Co-CEO, Dave Bagley, comments, “I have never seen a company more focused on scientific development than Max International.” Through Dr. Nagasawa’s efforts, the company has created an innovative line of supplements that help to promote a healthy lifestyle.

To learn more about Max International’s products or resale opportunities, please visit: http://www.max.com/max/max/full/us/en/overview. To inquire further about Max International, please contact Larry Lowe at larry(at)max.com.

About Max International, LLC:
Max International, LLC was founded in 2007 and currently conducts operations in the United States, Canada, Australia, New Zealand, Colombia, El Salvador, Singapore, Malaysia, the Philippines, Hong Kong, and Ghana through a direct sales force, made up of more than 100,000 home-based distributors. Its line of uniquely formulated health products employ proprietary health technology, including the patented RiboCeine™ compound, a revolutionary nutrient that helps promote healthy cell functioning and overall well-being. Max International’s driving goal is to provide the opportunity for individuals around the world to share the groundbreaking products with others to help promote wellness and health.


Contact